Horizon Pharma (HZNP) Lowers FY16 adj-EBITDA Guidance on Higher Expenses
Go back to Horizon Pharma (HZNP) Lowers FY16 adj-EBITDA Guidance on Higher ExpensesHORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $116.30 | 52 Week High | $23.44 | |||
Open | $116.30 | 52 Week Low | $13.06 | |||
Day High | $116.30 | P/E | N/A | |||
Day Low | $116.30 | EPS | $-0.96 | |||
Volume | 300,624 |